• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524INT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Pleural Effusion (2010); Urinary Tract Infection (2120); Vomiting (2144); Heart Failure/Congestive Heart Failure (4446); Renal Impairment (4499)
Event Date 01/14/2022
Event Type  Injury  
Event Description
It was reported that dialysis needed to be started due to acute renal dysfunction after the implant procedure.The patient vomited, once with a small amount of blood.The patient had right heart failure and had inotropic therapy more than seven days post implant.The patient had pleural effusion in the left pleural cavity.A pleural puncture was performed.
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
The patient also received parenteral antibiotics for urinary tract infection and remdesivir for covid-19 infection.The right heart failure existed prior to left ventricular assist device (lvad) implant, however, the renal function did not exist prior to lvad implant.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a specific cause for the reported events (right heart failure, bleeding, renal dysfunction, infection, patient condition) as well as a direct correlation to heartmate 3 left ventricular assist system (lvas), serial number (b)(6), could not be conclusively be determined through this evaluation.The patient remains ongoing on heartmate 3 left ventricular assist system (lvas), serial number (b)(6), with no further issues reported at this time.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specification.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu) and the heartmate 3 lvas patient handbook are currently available.Section 1 of the ifu, ¿introduction¿, lists right heart failure, bleeding, and renal dysfunction as potential adverse events that may be associated with the use of the heartmate 3 lvas.Section 6 of the ifu, ¿patient care and management¿, discusses the potential development of right heart failure following implant and outlines the associated treatment options.This section also provides information regarding the recommended anticoagulation regimen, including international normalized ratio (inr) values, as well as suggested anticoagulation modifications in the event that there is a risk of bleeding.Although no device-related infections were reported for this event, the ifu lists infection as an adverse event that may be associated with the use of heartmate 3 lvas.Both the ifu and patient handbook provide care instructions in regard to preventing infection.No further information was provided.The manufacturer is closing the file on this event.
 
Manufacturer Narrative
No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key13515173
MDR Text Key285855025
Report Number2916596-2022-00655
Device Sequence Number1
Product Code DSQ
Combination Product (y/n)N
Reporter Country CodeEZ
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/11/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/17/2023
Device Model Number106524INT
Device Lot Number8204761
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/15/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/02/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age57 YR
Patient SexMale
Patient Weight92 KG
-
-